Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

• Status: Suspended
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Milton S. Hershey Medical Center
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

1. Complains of symptoms suggestive of post-dural puncture headache

2. Has a history of dural puncture (lumbar puncture or accidental dural puncture during epidural placement) within the previous 7 days

3. Fluent in written and spoken English

Exclusion Criteria:

1. Those with a known history of hypersensitivity to local anesthetics of the amide type or to other components of GLYDO

2. Those with any congenital or acquired, anatomical deformity of the nostril, which preclude performing the block

3. Those who refuse to consent to participate in the study

4. Patients who have had a failed epidural blood patch

5. Cognitive Impairment

6. Prisoner